ADC Therapeutics to Host First Quarter 2026 Financial Results Conference Call on May 4, 2026
LAUSANNE, Switzerland, April 27, 2026 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field...
Read moreDetails